What AVANOS MEDICAL, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 4 |
| Total trades | 0 | 39 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 898,190 |
| Disposed | 0 | 1,404,377 |
| Net activity | +0 | −506,187 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Blackford Gary | Director | Jul 27 | Disposition to Issuer · D | −79,590 | $25.00 | −$1.99M | 0 |
| Blackford Gary | Director | Jul 27 | Disposition to Issuer · D | −40,000 | $25.00 | −$1M | 0 |
| Oleary Patrick J | Director | Jul 27 | Disposition to Issuer · D | −54,640 | $25.00 | −$1.37M | 0 |
| Egbuonu-Davis Lisa | Director | Jul 27 | Disposition to Issuer · D | −13,811 | $25.00 | −$345K | 0 |
| Franchini Indrani Lall | Director | Jul 27 | Disposition to Issuer · D | −4,817 | $25.00 | −$120K | 0 |
| Galovan Scott Michael | SVP, Chief Financial Officer | Jul 27 | Disposition to Issuer · D | −96,121 | $25.00 | −$2.4M | 0 |
| Galovan Scott Michael | SVP, Chief Financial Officer | Jul 27 | Grant / award · A | +96,121 | — | — | 96,121 |
| Galovan Scott Michael | SVP, Chief Financial Officer | Jul 27 | Disposition to Issuer · D | −135,596 | $25.00 | −$3.39M | 0 |
| Shimer Julie Ann | Director | Jul 27 | Disposition to Issuer · D | −50,090 | $25.00 | −$1.25M | 0 |
| Pacitti David | Chief Executive Officer | Jul 27 | Disposition to Issuer · D | −444,730 | $25.00 | −$11.1M | 0 |
| Pacitti David | Chief Executive Officer | Jul 27 | Grant / award · A | +444,730 | — | — | 444,730 |
| Pacitti David | Chief Executive Officer | Jul 27 | Disposition to Issuer · D | −322,194 | $25.00 | −$8.05M | 0 |
| Delgado Sigfrido | SVP, Operations | Jul 27 | Disposition to Issuer · D | −54,886 | $25.00 | −$1.37M | 0 |
| Delgado Sigfrido | SVP, Operations | Jul 27 | Grant / award · A | +54,886 | — | — | 54,886 |
| Delgado Sigfrido | SVP, Operations | Jul 27 | Disposition to Issuer · D | −55,741 | $25.00 | −$1.39M | 0 |
| Delgado Sigfrido | SVP, Operations | Apr 22 | Withheld — tax / exercise cost · F | −4,264 | $24.64 | −$105K | 55,741 |
| Galovan Scott Michael | SVP, Chief Financial Officer | Apr 22 | Withheld — tax / exercise cost · F | −4,228 | $24.64 | −$104K | 135,596 |
| Pacitti David | Chief Executive Officer | Apr 14 | Withheld — tax / exercise cost · F | −21,194 | $14.53 | −$308K | 322,194 |
| Hurley John Joseph | Principal Accounting Officer | Mar 13 | Grant / award · A | +2,211 | — | — | 13,592 |
| Pacitti David | Chief Executive Officer | Mar 13 | Grant / award · A | +101,341 | — | — | 343,388 |
Loading...